ketoprofen has been researched along with Cystic Fibrosis in 5 studies
Ketoprofen: An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis.
ketoprofen : An oxo monocarboxylic acid that consists of propionic acid substituted by a 3-benzoylphenyl group at position 2.
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, WJ | 1 |
| Goeckeler-Fried, JL | 1 |
| Havasi, V | 1 |
| Chiang, A | 1 |
| Rowe, SM | 1 |
| Plyler, ZE | 1 |
| Hong, JS | 1 |
| Mazur, M | 1 |
| Piazza, GA | 1 |
| Keeton, AB | 1 |
| White, EL | 1 |
| Rasmussen, L | 1 |
| Weissman, AM | 1 |
| Denny, RA | 1 |
| Brodsky, JL | 1 |
| Sorscher, EJ | 1 |
| Stigliani, M | 2 |
| Aquino, RP | 2 |
| Del Gaudio, P | 2 |
| Mencherini, T | 1 |
| Sansone, F | 1 |
| Russo, P | 2 |
| Manniello, MD | 1 |
| Zegarra-Moran, O | 1 |
| Galietta, L | 1 |
| Minicucci, L | 1 |
| Casciaro, R | 1 |
| Garofalo, E | 1 |
| Incarnato, L | 1 |
| Groutas, WC | 1 |
| Huang, H | 1 |
| Venkataraman, R | 1 |
| Houser-Archield, N | 1 |
| Epp, JB | 1 |
| Way, BA | 1 |
| Wilhite, TR | 1 |
| Smith, CH | 1 |
| Landt, M | 1 |
5 other studies available for ketoprofen and Cystic Fibrosis
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regu | 2016 |
Non-steroidal anti-inflammatory drug for pulmonary administration: design and investigation of ketoprofen lysinate fine dry powders.
Topics: Administration, Inhalation; Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scann | 2013 |
Rheological Properties of Cystic Fibrosis Bronchial Secretion and in Vitro Drug Permeation Study: The Effect of Sodium Bicarbonate.
Topics: Administration, Inhalation; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Bronchi; Cys | 2016 |
Dual-action inhibitors of proteolytic enzymes: potential therapeutic agents for cystic fibrosis and related ailments.
Topics: Amino Acid Sequence; Aspirin; Cystic Fibrosis; Drug Design; Humans; In Vitro Techniques; Ketoprofen; | 1993 |
Measurement of plasma ibuprofen by gas chromatography-mass spectrometry.
Topics: Chromatography, High Pressure Liquid; Cystic Fibrosis; Drug Monitoring; Fenoprofen; Gas Chromatograp | 1997 |